Article

CRISPR/Cas9 Technology Providing a Therapeutic Landscape of Metastatic Prostate Cancer

2024-11-04

Abstract excerpt

Prostate cancer (PCa) is the most prevalent malignancy and the second leading cause of can-cer-related death in men. Although current therapies can effectively manage the primary tumor, most patients with late-stage disease manifest with metastasis in different organs. From surgery to treatment intensification (TI), several combinations of therapies are administered to improve prognosis of patients with metastatic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fdce1844-6c07-570a-a004-c78a10548be9
DOI: 10.20944/preprints202411.0055.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9 Technology Providing a Therapeutic Landscape of Metastatic Prostate CancerDOI 10.20944/preprints202411.0055.v1Read

CRISPR Screen Contributes to Novel Target Discovery in Prostate CancerSemantic proximity Read

Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology with a special focus on androgen receptor signalingSemantic proximity Read

CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel driver of metastasis in prostate cancerSemantic proximity Read

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expressionSemantic proximity Read

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expressionSemantic proximity Read

CRISPR screening reveals SYCP3 as a key driver of metastasis in prostate cancerSemantic proximity Read

Integrative CRISPR-Cas9 Screening Reveals Lethal Genes Driving Metastasis and Prognosis in Prostate AdenocarcinomaSemantic proximity Read

Application and new findings of scRNA-seq and ST-seq in prostate cancerSemantic proximity Read

An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancerSemantic proximity Read

In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasisSemantic proximity Read

FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.Semantic proximity Read

Developing a Novel Enzalutamide-Resistant Prostate Cancer Model via AR F877L Mutation in LNCaP Cells.Semantic proximity Read